# POEMS syndrome presenting with Vibrio vulnificus–like cutaneous lesions: a CARE guidelines-compliant case report

**Authors:** Xiaomei Li, Bihong Lin, Liping Lin, Conghua Song

PMC · DOI: 10.3389/fmed.2025.1625877 · Frontiers in Medicine · 2025-07-08

## TL;DR

A rare case of POEMS syndrome presented with skin lesions resembling Vibrio vulnificus infection, expanding the known range of skin changes associated with this condition.

## Contribution

This is the first reported case of POEMS syndrome presenting with Vibrio vulnificus–like cutaneous lesions.

## Key findings

- The patient exhibited ecchymoses and hemorrhagic bullae resembling Vibrio vulnificus infection.
- Treatment with bortezomib plus dexamethasone led to resolution of skin lesions and improvement in neuropathy.
- VEGF measurement and immunofixation electrophoresis were crucial for diagnosis.

## Abstract

POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder, Skin changes) syndrome is a rare paraneoplastic disorder driven by a λ-restricted plasma cell clone. Cutaneous manifestations are common but typically limited to hyperpigmentation, hemangiomas, and sclerodermoid changes. We herein report the first case of POEMS syndrome presenting with skin lesions closely resembling those of Vibrio vulnificus infection.

A 65-year-old woman was admitted with malignant hypertension, refractory ascites, symmetrical thigh ecchymoses evolving into tense hemorrhagic bullae, and progressive sensorimotor polyneuropathy. Laboratory workup revealed thrombocytosis, hypoalbuminemia, acute kidney injury, an IgA-λ monoclonal band on serum immunofixation, and a markedly elevated VEGF level (729.7 pg./mL, reference range: 9–86 pg./mL). Electromyography confirmed a demyelinating neuropathy. Infectious, autoimmune, hepatic, renal, and malignant etiologies were systematically excluded. A multidisciplinary team reached the diagnosis of POEMS syndrome based on two mandatory criteria (polyneuropathy and monoclonal plasma cell disorder), one major criterion (elevated VEGF), and multiple minor criteria (extravascular volume overload, endocrinopathy, skin changes, thrombocytosis, organomegaly).

The patient received bortezomib plus dexamethasone, leading to gradual resolution of skin lesions, improvement of neuropathic symptoms, and reduction of VEGF levels. After six cycles, ascites resolved and neurological function partially recovered.

This case expands the spectrum of POEMS-associated skin changes to include V. vulnificus–like bullous lesions. “V. vulnificus–like” refers purely to morphological similarity and not microbiological confirmation. Awareness of such atypical presentations is essential for early recognition. Clinicians should consider POEMS syndrome in patients with unexplained multisystem involvement and vascular skin changes. VEGF measurement and immunofixation electrophoresis are essential tools for timely diagnosis.

## Linked entities

- **Proteins:** VEGFA (vascular endothelial growth factor A)
- **Chemicals:** bortezomib (PubChem CID 387447), dexamethasone (PubChem CID 5743)
- **Diseases:** POEMS syndrome (MONDO:0017364), Vibrio vulnificus infection (MONDO:0043297), malignant hypertension (MONDO:0006846), acute kidney injury (MONDO:0002492), polyneuropathy (MONDO:0001824)
- **Species:** Vibrio vulnificus (taxon 672)

## Full-text entities

- **Diseases:** volume overload (MESH:D019190), hyperpigmentation (MESH:D017495), hypoalbuminemia (MESH:D034141), cutaneous lesions (MESH:D009059), hemangiomas (MESH:D006391), malignant hypertension (MESH:D006974), Skin changes (MESH:D012871), V. vulnificus (MESH:C536348), demyelinating neuropathy (MESH:D003711), paraneoplastic disorder (MESH:D010257), neuropathic symptoms (MESH:D001750), thrombocytosis (MESH:D013922), bullous lesions (MESH:D001768), Endocrinopathy (MESH:C567425), Polyneuropathy (MESH:D011115), Monoclonal plasma cell disorder (MESH:D007952), Organomegaly (MESH:D016878), acute kidney injury (MESH:D058186), hemorrhagic (MESH:D006470), ascites (MESH:D001201)
- **Chemicals:** bortezomib (MESH:D000069286), dexamethasone (MESH:D003907)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12279499/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12279499/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12279499/full.md

---
Source: https://tomesphere.com/paper/PMC12279499